An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Renal Anemia

Non-interventional Study to Investigate Hemoglobin Levels and Dose Over Time in the Daily Use of Mircera for Renal Anemia in Larger Centers, and to Detect Differences Between Standard of Care in the Centers

This observational study will investigate hemoglobin levels and Mircera (methoxy polyethyleneglycol-epoetin beta) dose over time in patients with chronic kidney disease, and compare standards of care between centers. Data from each patient will be collected over 12 months of Mircera therapy.

Inclusion Criteria:

• adult patients, >/= 18 years of age
• chronic kidney disease
• informed consent for data transmission

Exclusion Criteria:

• serious hematological or infectious disease
• acute bleeding in the 16 weeks preceding data collection
• participation in an interventional trial
• female patients: pregnancy or breast-feeding